• FDA Rare Disease Hub Update

  Published On: 10/16/2024

• Abbott and Edwards Lifesciences Likely Successful TCET Candidates

  Published On: 10/07/2024

• 2027 Negotiated Drug Prices Potentially Start Lower?

  Published On: 10/03/2024

• FDA AdComm Reform is Not Coming Any Time Soon

  Published On: 10/02/2024

• Deja Vu: Healthcare Takes Backseat in Vance v. Walz

  Published On: 10/02/2024

• Medicare Advantage Landscape Files 2025

  Published On: 09/29/2024

• Medicaid MCO Guidance On Prior Auth

  Published On: 09/26/2024

• Novo CEO Testifies Today on GLP-1 Prices

  Published On: 09/24/2024

• Rare Pediatric Disease PRV Likely to Be Extended via Latest CR

  Published On: 09/23/2024

• Mixed Bag: Medicaid Drug & Rebate Final Rules

  Published On: 09/23/2024

• Appellate Court Gives PhRMA’s IRA Argument A Chance

  Published On: 09/22/2024

• ALERT: FTC Sues Big 3 PBMs

  Published On: 09/20/2024

• BIOSECURE Omitted from Senate NDAA Manager’s Amendment

  Published On: 09/20/2024

• House E&C Clears Telehealth Bill w/ PBM, Lab Payfors

  Published On: 09/18/2024

• PBM Reform (Still) Likely at Year End

  Published On: 09/12/2024

• House Passes BIOSECURE Act

  Published On: 09/09/2024

• BIOSECURE Heats… Then Cools?

  Published On: 09/03/2024

• Health Policy Catalyst Update – Aug. 29, 2024

  Published On: 08/29/2024

• Rare Disease Voucher Update

  Published On: 08/28/2024

• Kamala Harris on Healthcare

  Published On: 07/22/2024

Previous111213Next